Imperial College London

Professor Hani Gabra

Faculty of MedicineDepartment of Surgery & Cancer

Emeritus Professor of Medical Oncology
 
 
 
//

Contact

 

h.gabra Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

Garry Weston CentreCancer CentreHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Agarwal:2010:10.1016/j.ejca.2010.03.006,
author = {Agarwal, R and Gourley, C and Perren, TJ and Reed, N and Parkin, DE and Carty, K and Rustin, GJS and Gabra, H and Paul, J and Gore, ME and Kaye, SB},
doi = {10.1016/j.ejca.2010.03.006},
journal = {EUROPEAN JOURNAL OF CANCER},
pages = {2020--2026},
title = {First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series},
url = {http://dx.doi.org/10.1016/j.ejca.2010.03.006},
volume = {46},
year = {2010}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Agarwal,R
AU - Gourley,C
AU - Perren,TJ
AU - Reed,N
AU - Parkin,DE
AU - Carty,K
AU - Rustin,GJS
AU - Gabra,H
AU - Paul,J
AU - Gore,ME
AU - Kaye,SB
DO - 10.1016/j.ejca.2010.03.006
EP - 2026
PY - 2010///
SN - 0959-8049
SP - 2020
TI - First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): A feasibility study and comparative analysis of the SCOTROC series
T2 - EUROPEAN JOURNAL OF CANCER
UR - http://dx.doi.org/10.1016/j.ejca.2010.03.006
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280393700014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 46
ER -